EcoDrugPlus

Collagenase 3-Like

Ensembl ID : ENSSTUG00000018003
Gene Symbol: LOC115154375
2 Cross references
301 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSSTUG00000029851
Gene Symbol: LOC115148916
2 Cross references
301 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSSTUG00000039586
Gene Symbol: CSF1R
3 Cross references
200 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSSTUG00000006727
Gene Symbol: CSF1R
3 Cross references
57 Possible Orthologues:

Complement C5

Ensembl ID : ENSSTUG00000038463
Gene Symbol: C5
3 Cross references
216 Possible Orthologues:

Complement Factor D-Like

Ensembl ID : ENSSTUG00000040640
Gene Symbol: LOC115173057
3 Cross references
133 Possible Orthologues:

Corticotropin-Releasing Factor Receptor 1

Ensembl ID : ENSSTUG00000036868
Gene Symbol: LOC115170939
2 Cross references
196 Possible Orthologues:

Corticotropin-Releasing Factor Receptor 1-Like

Ensembl ID : ENSSTUG00000007670
Gene Symbol: LOC115196407
2 Cross references
197 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSSTUG00000051072
Gene Symbol: CCND1
3 Cross references
200 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSSTUG00000031480
Gene Symbol: CCND1
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSSTUG00000019455
Gene Symbol: CDK2
3 Cross references
196 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSSTUG00000050412
Gene Symbol: CDK7
3 Cross references
216 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).